Ignite Creation Date:
2025-12-24 @ 1:48 PM
Ignite Modification Date:
2026-04-18 @ 5:36 PM
Study NCT ID:
NCT01837095
Status:
COMPLETED
Last Update Posted:
2018-09-14
First Post:
2013-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer
Sponsor:
Polyphor Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
POL-7
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None